Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Antimicrobial Reports

A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age

Roilides, Emmanuel MD, PhD*; Carlesse, Fabianne MD, PhD; Leister-Tebbe, Heidi BSN; Conte, Umberto PharmD; Yan, Jean L. MS; Liu, Ping PhD§; Tawadrous, Margaret MD; Aram, Jalal A. MD; Queiroz-Telles, Flavio MD, PhD on behalf of the Anidulafungin A8851008 Pediatric Study Group

Author Information
The Pediatric Infectious Disease Journal: March 2019 - Volume 38 - Issue 3 - p 275-279
doi: 10.1097/INF.0000000000002237
  • Buy
  • SDC


Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.